Startup entity
All 1 tracked stories fall under one category: funding. Psilocybin is most often covered alongside Ibogaine, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 7.3. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline.
Last mentioned: Mar 17, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: funding. Psilocybin is most often covered alongside Ibogaine, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 7.3. Source depth averages 2 original sources per story, versus 2.6 across the same-window beat baseline. Psilocybin appears in 1 tracked Startup story from February 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Psilocybin. Shared-story counts are live from our verified record — not editorial picks.
Put Option Exercised
PsyLabs Ltd. formally exercises its rights under the Put Option Agreement with Psyence BioMed.
Strategic Investment Announced
Psyence BioMed announces it will make an equity investment in PsyLabs at fair market value.
Psyence Biomedical Ltd. (Nasdaq: PBM) has announced a strategic equity investment in PsyLabs Ltd. after the manufacturer exercised its rights under a previously established put option agreement. This move strengthens the relationship between the biopharmaceutical developer and its primary supplier of nature-derived psychedelic compounds.
Psilocybin is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
